Literature DB >> 8288246

Assignment of the human RT6 gene to 11q13 by PCR screening of somatic cell hybrids and in situ hybridization.

F Koch-Nolte1, F Haag, M Kühl, V van Heyningen, J Hoovers, K H Grzeschik, S Singh, H G Thiele.   

Abstract

RT6 is a T cell membrane protein that has attracted interest because a defect in RT6 expression is associated with susceptibility to autoimmune type I diabetes in DP-BB rats and NOD mice. Using PCR screening of human/rodent somatic cell hybrids and fluorescence in situ hybridization, we have determined that the gene for the human RT6 homologue is located at 11q13, centromeric to the gene for tyrosinase (TYR, albino locus) and telomeric to that for fibroblast growth factor 4 (FGF4). The data suggest that the human RT6 gene constitutes a new linkage group with TYR and the gene for olfactory marker protein (OMP) on 11q, which has a counterpart in mouse chromosome 7. Thus, in the human, the RT6 locus is dissociated from the hemoglobin beta chain locus (HBB) and its neighboring conserved linkage group at 11p15, in contrast to the mouse, in which RT6 shows a tighter linkage to Hbb than to Tyr. The results support the conclusion that there has been considerable intrachromosomal reshuffling of linked genes since the divergence of primates and rodents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8288246     DOI: 10.1006/geno.1993.1484

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  2 in total

1.  BglII identifies a frequent biallelic DNA polymorphism of the human RT6 gene.

Authors:  F Koch-Nolte; S Singh; F Haag; M Kühl; H G Thiele
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

2.  The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse.

Authors:  Gustavo Glowacki; Rickmer Braren; Kathrin Firner; Marion Nissen; Maren Kühl; Pedro Reche; Fernando Bazan; Marina Cetkovic-Cvrlje; Edward Leiter; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.